EYE 1.96% 25.0¢ nova eye medical limited

Yes, tbh I didn't go into the specifics that much, but to...

  1. 1,959 Posts.
    lightbulb Created with Sketch. 325
    Yes, tbh I didn't go into the specifics that much, but to counter your analysis, there are limitations with your article also.

    The main bearing is that it denotes that there is little confirmed clinical evidence that canaloplasty is superior to trabeculectomy. The current gold standard is still trabeculectomy for glaucoma.

    There has been a clinical trial performed comparing TE vs CP, and it has been determined that while TE was less safe, it demonstrated superior efficacy. This study was completed back >10 years ago, but I'm not sure if there has been any updates comparison trial..

    I am a holder, but I want to provide a balanced view of how much market penetration canaloplasty has.
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
(20min delay)
Last
25.0¢
Change
-0.005(1.96%)
Mkt cap ! $57.20M
Open High Low Value Volume
26.0¢ 26.0¢ 25.0¢ $99.31K 394.1K

Buyers (Bids)

No. Vol. Price($)
3 60889 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 181476 3
View Market Depth
Last trade - 15.58pm 19/07/2024 (20 minute delay) ?
EYE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.